Gene Activity List

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 34 of 1714:
24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44
Gene Compound Assay Inh Ic50 Ki View
sodium channel, voltage-gated, type XI, alpha DOXEPIN Sodium Channel, Site 2 74% 2.542uM 2.319uM View
sodium channel, voltage-gated, type I, beta DOXEPIN Sodium Channel, Site 2 74% 2.542uM 2.319uM View
sodium channel, voltage-gated, type 10, alpha polypeptide DOXEPIN Sodium Channel, Site 2 74% 2.542uM 2.319uM View
sodium channel, voltage-gated, type IV, alpha polypeptide DOXEPIN Sodium Channel, Site 2 74% 2.542uM 2.319uM View
sodium channel, voltage-gated, type V, alpha polypeptide DOXEPIN Sodium Channel, Site 2 74% 2.542uM 2.319uM View
sodium channel, voltage-gated, type II, beta DOXEPIN Sodium Channel, Site 2 74% 2.542uM 2.319uM View
sodium channel, nonvoltage-gated 1 alpha DOXEPIN Sodium Channel, Site 2 74% 2.542uM 2.319uM View
sodium channel, nonvoltage-gated 1 gamma DOXEPIN Sodium Channel, Site 2 74% 2.542uM 2.319uM View
sodium channel, nonvoltage-gated 1 beta DOXEPIN Sodium Channel, Site 2 74% 2.542uM 2.319uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide DOXEPIN Sodium Channel, Site 2 74% 2.542uM 2.319uM View
sodium channel, voltage-gated, type XI, alpha DOXEPIN Sodium Channel, Site 2 74% 2.542uM 2.319uM View
sodium channel, nonvoltage-gated 1, gamma DOXEPIN Sodium Channel, Site 2 74% 2.542uM 2.319uM View
sodium channel, nonvoltage-gated 1, delta DOXEPIN Sodium Channel, Site 2 74% 2.542uM 2.319uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) DOXEPIN Sodium Channel, Site 2 74% 2.542uM 2.319uM View
sodium channel, nonvoltage-gated 1 alpha DOXEPIN Sodium Channel, Site 2 74% 2.542uM 2.319uM View
sodium channel, voltage-gated, type X, alpha DOXEPIN Sodium Channel, Site 2 74% 2.542uM 2.319uM View
sodium channel, voltage-gated, type IX, alpha DOXEPIN Sodium Channel, Site 2 74% 2.542uM 2.319uM View
sodium channel, voltage gated, type VIII, alpha DOXEPIN Sodium Channel, Site 2 74% 2.542uM 2.319uM View
sodium channel, voltage-gated, type VII, alpha DOXEPIN Sodium Channel, Site 2 74% 2.542uM 2.319uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) DOXEPIN Sodium Channel, Site 2 74% 2.542uM 2.319uM View
sodium channel, voltage-gated, type IV, beta DOXEPIN Sodium Channel, Site 2 74% 2.542uM 2.319uM View
sodium channel, voltage-gated, type IV, alpha DOXEPIN Sodium Channel, Site 2 74% 2.542uM 2.319uM View
sodium channel, voltage-gated, type III, alpha DOXEPIN Sodium Channel, Site 2 74% 2.542uM 2.319uM View
sodium channel, voltage-gated, type II, beta DOXEPIN Sodium Channel, Site 2 74% 2.542uM 2.319uM View
sodium channel, voltage-gated, type II, alpha 2 DOXEPIN Sodium Channel, Site 2 74% 2.542uM 2.319uM View
sodium channel, voltage-gated, type I, beta DOXEPIN Sodium Channel, Site 2 74% 2.542uM 2.319uM View
sodium channel, voltage-gated, type I, alpha DOXEPIN Sodium Channel, Site 2 74% 2.542uM 2.319uM View
adrenergic receptor, alpha 2a TICLOPIDINE Imidazoline I2, Central 74% 2.239uM 1.493uM View
adrenergic receptor, alpha 2c (Non-specific probe) TICLOPIDINE Imidazoline I2, Central 74% 2.239uM 1.493uM View
Sigma-2 Receptor TICLOPIDINE Sigma2 74% 3.262uM 2.007uM View
Sigma-2 Receptor LABETALOL Sigma2 74% 2.818uM 1.734uM View
Sigma-2 Receptor R-(+)-PROPRANOLOL Sigma2 74% 3.448uM 2.122uM View
5-hydroxytryptamine (serotonin) receptor 2B HALOPERIDOL Serotonin 5-HT2B 74% 2.05uM 1.305uM View
phosphodiesterase 4A, cAMP specific GENISTEIN Phosphodiesterase PDE4 74% 10.924uM NoneNone View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 LOPERAMIDE Serotonin Transporter 74% 2.202uM 1.17uM View
adrenergic receptor, alpha 1a LOPERAMIDE Adrenergic alpha1A 74% 6.219uM 2.517uM View
calcium channel, voltage-dependent, gamma subunit 5 SERTRALINE Calcium Channel Type L, Benzothiazepine 74% 1.468uM 1.3049uM View
calcium channel, voltage-dependent, gamma subunit 4 SERTRALINE Calcium Channel Type L, Benzothiazepine 74% 1.468uM 1.3049uM View
calcium channel, voltage-dependent, gamma subunit 3 SERTRALINE Calcium Channel Type L, Benzothiazepine 74% 1.468uM 1.3049uM View
sodium channel associated protein 1 ACONITINE Sodium Channel, Site 2 74% 4.49uM 4.096uM View
sodium channel associated protein 2 ACONITINE Sodium Channel, Site 2 74% 4.49uM 4.096uM View
sodium channel, voltage-gated, type III, beta ACONITINE Sodium Channel, Site 2 74% 4.49uM 4.096uM View
sodium channel, voltage-gated, type I, alpha ACONITINE Sodium Channel, Site 2 74% 4.49uM 4.096uM View
sodium channel, voltage-gated, type IX, alpha ACONITINE Sodium Channel, Site 2 74% 4.49uM 4.096uM View
sodium channel, voltage-gated, type VII, alpha ACONITINE Sodium Channel, Site 2 74% 4.49uM 4.096uM View
amiloride-sensitive cation channel 5, intestinal ACONITINE Sodium Channel, Site 2 74% 4.49uM 4.096uM View
sodium channel, voltage-gated, type III, beta ACONITINE Sodium Channel, Site 2 74% 4.49uM 4.096uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide ACONITINE Sodium Channel, Site 2 74% 4.49uM 4.096uM View
sodium channel, voltage-gated, type XI, alpha ACONITINE Sodium Channel, Site 2 74% 4.49uM 4.096uM View
sodium channel, voltage-gated, type I, beta ACONITINE Sodium Channel, Site 2 74% 4.49uM 4.096uM View
sodium channel, voltage-gated, type 10, alpha polypeptide ACONITINE Sodium Channel, Site 2 74% 4.49uM 4.096uM View
sodium channel, voltage-gated, type IV, alpha polypeptide ACONITINE Sodium Channel, Site 2 74% 4.49uM 4.096uM View
sodium channel, voltage-gated, type V, alpha polypeptide ACONITINE Sodium Channel, Site 2 74% 4.49uM 4.096uM View
sodium channel, voltage-gated, type II, beta ACONITINE Sodium Channel, Site 2 74% 4.49uM 4.096uM View
sodium channel, nonvoltage-gated 1 alpha ACONITINE Sodium Channel, Site 2 74% 4.49uM 4.096uM View
sodium channel, nonvoltage-gated 1 gamma ACONITINE Sodium Channel, Site 2 74% 4.49uM 4.096uM View
sodium channel, nonvoltage-gated 1 beta ACONITINE Sodium Channel, Site 2 74% 4.49uM 4.096uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide ACONITINE Sodium Channel, Site 2 74% 4.49uM 4.096uM View
sodium channel, voltage-gated, type XI, alpha ACONITINE Sodium Channel, Site 2 74% 4.49uM 4.096uM View
sodium channel, nonvoltage-gated 1, gamma ACONITINE Sodium Channel, Site 2 74% 4.49uM 4.096uM View
sodium channel, nonvoltage-gated 1, delta ACONITINE Sodium Channel, Site 2 74% 4.49uM 4.096uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) ACONITINE Sodium Channel, Site 2 74% 4.49uM 4.096uM View
sodium channel, nonvoltage-gated 1 alpha ACONITINE Sodium Channel, Site 2 74% 4.49uM 4.096uM View
sodium channel, voltage-gated, type X, alpha ACONITINE Sodium Channel, Site 2 74% 4.49uM 4.096uM View
sodium channel, voltage-gated, type IX, alpha ACONITINE Sodium Channel, Site 2 74% 4.49uM 4.096uM View
sodium channel, voltage gated, type VIII, alpha ACONITINE Sodium Channel, Site 2 74% 4.49uM 4.096uM View
sodium channel, voltage-gated, type VII, alpha ACONITINE Sodium Channel, Site 2 74% 4.49uM 4.096uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) ACONITINE Sodium Channel, Site 2 74% 4.49uM 4.096uM View
sodium channel, voltage-gated, type IV, beta ACONITINE Sodium Channel, Site 2 74% 4.49uM 4.096uM View
sodium channel, voltage-gated, type IV, alpha ACONITINE Sodium Channel, Site 2 74% 4.49uM 4.096uM View
sodium channel, voltage-gated, type III, alpha ACONITINE Sodium Channel, Site 2 74% 4.49uM 4.096uM View
sodium channel, voltage-gated, type II, beta ACONITINE Sodium Channel, Site 2 74% 4.49uM 4.096uM View
sodium channel, voltage-gated, type II, alpha 2 ACONITINE Sodium Channel, Site 2 74% 4.49uM 4.096uM View
sodium channel, voltage-gated, type I, beta ACONITINE Sodium Channel, Site 2 74% 4.49uM 4.096uM View
sodium channel, voltage-gated, type I, alpha ACONITINE Sodium Channel, Site 2 74% 4.49uM 4.096uM View
cholinergic receptor, muscarinic 5 BETAMETHASONE PHOSPHATE Muscarinic M5 74% 7.861uM 5.648uM View
adrenergic receptor, alpha 2b TERAZOSIN Adrenergic alpha2C 74% 6.042uM .878uM View
adrenergic receptor, alpha 2c (Non-specific probe) TERAZOSIN Adrenergic alpha2C 74% 6.042uM .878uM View
tachykinin receptor 1 TAMOXIFEN Tachykinin NK1 74% 15.656uM 8.54uM View
dopamine receptor D4 TAMOXIFEN Dopamine D4.2 74% 11.161uM 3.913uM View
adenosine A1 receptor TAMOXIFEN Adenosine A1 74% 23.767uM 13.864uM View
calcium channel, voltage-dependent, gamma subunit 8 NIFEDIPINE Calcium Channel Type L, Phenylalkylamine 74% .878uM .853uM View
calcium channel, voltage-dependent, gamma subunit 7 NIFEDIPINE Calcium Channel Type L, Phenylalkylamine 74% .878uM .853uM View
calcium channel, voltage-dependent, gamma subunit 6 NIFEDIPINE Calcium Channel Type L, Phenylalkylamine 74% .878uM .853uM View
calcium channel, voltage-dependent, gamma subunit 5 NIFEDIPINE Calcium Channel Type L, Phenylalkylamine 74% .878uM .853uM View
calcium channel, voltage-dependent, gamma subunit 4 NIFEDIPINE Calcium Channel Type L, Phenylalkylamine 74% .878uM .853uM View
calcium channel, voltage-dependent, gamma subunit 3 NIFEDIPINE Calcium Channel Type L, Phenylalkylamine 74% .878uM .853uM View
calcium channel, voltage-dependent, gamma subunit 2 NIFEDIPINE Calcium Channel Type L, Phenylalkylamine 74% .878uM .853uM View
calcium channel, voltage-dependent, gamma subunit 1 NIFEDIPINE Calcium Channel Type L, Phenylalkylamine 74% .878uM .853uM View
calcium channel, voltage-dependent, beta 4 subunit NIFEDIPINE Calcium Channel Type L, Phenylalkylamine 74% .878uM .853uM View
calcium channel, voltage-dependent, beta 3 subunit NIFEDIPINE Calcium Channel Type L, Phenylalkylamine 74% .878uM .853uM View
calcium channel, voltage-dependent, beta 2 subunit NIFEDIPINE Calcium Channel Type L, Phenylalkylamine 74% .878uM .853uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit NIFEDIPINE Calcium Channel Type L, Phenylalkylamine 74% .878uM .853uM View
calcium channel, voltage-dependent, alpha 1F subunit NIFEDIPINE Calcium Channel Type L, Phenylalkylamine 74% .878uM .853uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit NIFEDIPINE Calcium Channel Type L, Phenylalkylamine 74% .878uM .853uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit NIFEDIPINE Calcium Channel Type L, Phenylalkylamine 74% .878uM .853uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit NIFEDIPINE Calcium Channel Type L, Phenylalkylamine 74% .878uM .853uM View
calcium channel, voltage-dependent, beta 1 subunit NIFEDIPINE Calcium Channel Type L, Phenylalkylamine 74% .878uM .853uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit NIFEDIPINE Calcium Channel Type L, Phenylalkylamine 74% .878uM .853uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit NIFEDIPINE Calcium Channel Type L, Phenylalkylamine 74% .878uM .853uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 NIFEDIPINE Calcium Channel Type L, Phenylalkylamine 74% .878uM .853uM View
5-hydroxytryptamine (serotonin) receptor 1A CISAPRIDE Serotonin 5-HT1A 74% 2.829uM 1.617uM View
phosphodiesterase 4A, cAMP specific DIPYRIDAMOLE Phosphodiesterase PDE4 74% 1.579uM NoneNone View
potassium voltage-gated channel, subfamily H, member 8 CARVEDILOL Potassium Channel HERG 74% 4.1193uM 3.3749uM View
potassium voltage-gated channel, subfamily H (eag-related), member 6 CARVEDILOL Potassium Channel HERG 74% 4.1193uM 3.3749uM View
potassium voltage-gated channel, subfamily H (eag-related), member 7 CARVEDILOL Potassium Channel HERG 74% 4.1193uM 3.3749uM View
potassium voltage-gated channel, subfamily H (eag-related), member 2 CARVEDILOL Potassium Channel HERG 74% 4.1193uM 3.3749uM View
potassium voltage-gated channel, subfamily H (eag-related), member 5 CARVEDILOL Potassium Channel HERG 74% 4.1193uM 3.3749uM View
potassium voltage-gated channel, subfamily H (eag-related), member 3 CARVEDILOL Potassium Channel HERG 74% 4.1193uM 3.3749uM View
potassium voltage-gated channel, subfamily H (eag-related), member 4 CARVEDILOL Potassium Channel HERG 74% 4.1193uM 3.3749uM View
potassium voltage-gated channel, subfamily H (eag-related), member 1 CARVEDILOL Potassium Channel HERG 74% 4.1193uM 3.3749uM View
potassium voltage-gated channel, subfamily H (eag-related), member 1 CARVEDILOL Potassium Channel HERG 74% 4.1193uM 3.3749uM View
Sigma-2 Receptor BUPROPION Sigma2 74% 2.3156uM 1.425uM View
cholinergic receptor, muscarinic 4 PERHEXILINE Muscarinic M4 74% 3.5919uM .5009uM View
5-hydroxytryptamine receptor 6 DESLORATADINE Serotonin 5-HT6 74% 2.171uM 1.008uM View
5-hydroxytryptamine receptor 6 METHAPYRILENE Serotonin 5-HT6 74% 3.091uM 1.435uM View
5-hydroxytryptamine (serotonin) receptor 2B MONTELUKAST Serotonin 5-HT2B 74% 6.256uM 3.981uM View
5-hydroxytryptamine (serotonin) receptor 2A IMATINIB Serotonin 5-HT2A 74% 1.891uM .54uM View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) IODOQUINOL Protein Tyrosine Kinase, HER2 Receptor 74% 8.577uM NoneNone View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) IODOQUINOL Protein Tyrosine Kinase, HER2 Receptor 74% 8.577uM NoneNone View
mitogen activated protein kinase 3 HYDROXYPROGESTERONE Protein Serine/Threonine Kinase, ERK1 74% 3.157uM NoneNone View
mitogen-activated protein kinase 3 HYDROXYPROGESTERONE Protein Serine/Threonine Kinase, ERK1 74% 3.157uM NoneNone View
opioid receptor, delta 1 MONTELUKAST Opiate delta 74% 4.795uM 1.69uM View
Cytochrom P450-2D6 monooxygenase BERBERINE CHLORIDE CYP450-2D6 Inhibition 74% 4.5042uM NoneNone View
Cytochrom P450-2D6 monooxygenase CLOMIPHENE CYP450-2D6 Inhibition 74% 10uM NoneNone View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) CILOSTAZOL CYP450-2C9 Inhibition 74% 10uM NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 CILOSTAZOL CYP450-2C9 Inhibition 74% 10uM NoneNone View
adrenergic receptor, alpha 2b CLOSANTEL Adrenergic alpha2B 74% 1.8uM .8219uM View
adrenergic receptor, alpha 2b DOBUTAMINE Adrenergic alpha2B 74% 2.966uM 1.354uM View
endothelin receptor type A GRAMICIDIN Endothelin ETA 74% 2.983uM 1.835uM View
dopamine receptor D1A ABAMECTIN Dopamine D1 74% 6.119uM 3.06uM View
adrenergic receptor, beta 1 ERGOTAMINE Adrenergic beta1 74% 4.142uM 2.392uM View
adrenergic, beta-1-, receptor ERGOTAMINE Adrenergic beta1 74% 4.142uM 2.392uM View
5-hydroxytryptamine (serotonin) receptor 5B DIHYDROERGOCRISTINE MESYLATE Serotonin 5-HT4 74% 4.912uM .819uM View
5-hydroxytryptamine (serotonin) receptor 4 DIHYDROERGOCRISTINE MESYLATE Serotonin 5-HT4 74% 4.912uM .819uM View
cholinergic receptor, muscarinic 5 QUETIAPINE Muscarinic M5 74% 3.0007uM 2.1559uM View
adrenergic receptor, alpha 2a QUETIAPINE Imidazoline I2, Central 74% 1.5211uM 1.0141uM View
adrenergic receptor, alpha 2c (Non-specific probe) QUETIAPINE Imidazoline I2, Central 74% 1.5211uM 1.0141uM View
cytochrome P450, family 3, subfamily a, polypeptide 13 NELFINAVIR CYP450-3A4 Inhibition 74% 2uM NoneNone View
adrenergic receptor, alpha 1b SILDENAFIL Adrenergic alpha1B 74% 1.457uM .806uM View
adrenergic receptor, alpha 2a PENTAMIDINE Imidazoline I2, Central 74% 3.524uM 2.349uM View
adrenergic receptor, alpha 2c (Non-specific probe) PENTAMIDINE Imidazoline I2, Central 74% 3.524uM 2.349uM View
aldo-keto reductase family 1, member B4 (aldose reductase) PIOGLITAZONE Aldose Reductase 74% 13.2uM NoneNone View
aldo-keto reductase family 1, member B1 (aldose reductase) PIOGLITAZONE Aldose Reductase 74% 13.2uM NoneNone View
aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) PIOGLITAZONE Aldose Reductase 74% 13.2uM NoneNone View
aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) PIOGLITAZONE Aldose Reductase 74% 13.2uM NoneNone View
monoamine oxidase A ETHYNODIOL DIACETATE Monoamine Oxidase MAOA 74% 4.29uM NoneNone View
monoamine oxidase A ETHYNODIOL DIACETATE Monoamine Oxidase MAOA 74% 4.29uM NoneNone View
adrenergic receptor, alpha 2a SULPIRIDE Adrenergic alpha2A 74% 2.019uM .757uM View
cholinergic receptor, muscarinic 5 PIPAMAZINE Muscarinic M5 74% 3.144uM 2.259uM View
melanocortin 5 receptor MICONAZOLE Melanocortin MC5 74% 22.607uM 21.206uM View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 KETOCONAZOLE Dopamine Transporter 74% 23.517uM 18.685uM View
aldo-keto reductase family 1, member B4 (aldose reductase) INDOMETHACIN Aldose Reductase 74% 3.631uM NoneNone View
aldo-keto reductase family 1, member B1 (aldose reductase) INDOMETHACIN Aldose Reductase 74% 3.631uM NoneNone View
aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) INDOMETHACIN Aldose Reductase 74% 3.631uM NoneNone View
aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) INDOMETHACIN Aldose Reductase 74% 3.631uM NoneNone View
adrenergic receptor, alpha 1b DESLORATADINE Adrenergic alpha1B 74% 3.623uM 2.005uM View
mitogen activated protein kinase 14 4-OCTYLPHENOL Protein Serine/Threonine Kinase, p38alpha 74% 15.016uM NoneNone View
mitogen-activated protein kinase 14 4-OCTYLPHENOL Protein Serine/Threonine Kinase, p38alpha 74% 15.016uM NoneNone View
Protein-tyrosine kinase, Fyn 3-METHYLCHOLANTHRENE Protein Tyrosine Kinase, Fyn 74% 25.177uM NoneNone View
5-hydroxytryptamine (serotonin) receptor 1B AMITRIPTYLINE Serotonin 5-HT1B 74% 3.73uM 1.695uM View
Cytochrom P450-2C19 monooxygenase CLOTRIMAZOLE CYP450-2C19 Inhibition 74% .016uM NoneNone View
cholinergic receptor, muscarinic 2 AMIODARONE Muscarinic M2 74% 5.08uM 1.806uM View
A3 adenosine receptor AMIODARONE Adenosine A3 74% 17.547uM 9.918uM View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) TROPICAMIDE CYP450-2C9 Inhibition 74% 1uM NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 TROPICAMIDE CYP450-2C9 Inhibition 74% 1uM NoneNone View
sodium channel, voltage-gated, type IV, beta ACONITINE Sodium Channel, Site 2 74% 4.49uM 4.096uM View
sodium channel, voltage-gated, type IV, alpha polypeptide OXYMETAZOLINE Sodium Channel, Site 2 73% 3.45uM 3.148uM View
sodium channel, voltage-gated, type V, alpha polypeptide OXYMETAZOLINE Sodium Channel, Site 2 73% 3.45uM 3.148uM View
sodium channel, voltage-gated, type II, beta OXYMETAZOLINE Sodium Channel, Site 2 73% 3.45uM 3.148uM View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 ORPHENADRINE Adrenergic, Norepinephrine Transporter 73% 2.666uM 2.643uM View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 EBASTINE Serotonin Transporter 73% 1.2287uM .6528uM View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 DOMPERIDONE Adrenergic, Norepinephrine Transporter 73% 2.614uM 2.593uM View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 PROMETHAZINE Serotonin Transporter 73% 4.01uM 2.13uM View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 CETYLPYRIDINIUM BROMIDE Dopamine Transporter 73% 6.279uM 4.989uM View
dopamine receptor D1A PROMETHAZINE Dopamine D1 73% 2.744uM 1.372uM View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 LACIDIPINE Adrenergic, Norepinephrine Transporter 73% 5.735uM 5.687uM View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 RALOXIFENE Serotonin Transporter 73% 3.576uM 1.9uM View
5-hydroxytryptamine (serotonin) receptor 1A DAPIPRAZOLE Serotonin 5-HT1A 73% 2.06uM 1.177uM View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) BENZETHONIUM CHLORIDE Protein Tyrosine Kinase, HER2 Receptor 73% 2.084uM NoneNone View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) BENZETHONIUM CHLORIDE Protein Tyrosine Kinase, HER2 Receptor 73% 2.084uM NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 PHENTOLAMINE Calcium Channel Type L, Phenylalkylamine 73% .746uM .725uM View
calcium channel, voltage-dependent, gamma subunit 7 PHENTOLAMINE Calcium Channel Type L, Phenylalkylamine 73% .746uM .725uM View
calcium channel, voltage-dependent, gamma subunit 6 PHENTOLAMINE Calcium Channel Type L, Phenylalkylamine 73% .746uM .725uM View
calcium channel, voltage-dependent, gamma subunit 5 PHENTOLAMINE Calcium Channel Type L, Phenylalkylamine 73% .746uM .725uM View
calcium channel, voltage-dependent, gamma subunit 4 PHENTOLAMINE Calcium Channel Type L, Phenylalkylamine 73% .746uM .725uM View
calcium channel, voltage-dependent, gamma subunit 3 PHENTOLAMINE Calcium Channel Type L, Phenylalkylamine 73% .746uM .725uM View
calcium channel, voltage-dependent, gamma subunit 2 PHENTOLAMINE Calcium Channel Type L, Phenylalkylamine 73% .746uM .725uM View
calcium channel, voltage-dependent, gamma subunit 1 PHENTOLAMINE Calcium Channel Type L, Phenylalkylamine 73% .746uM .725uM View
calcium channel, voltage-dependent, beta 4 subunit PHENTOLAMINE Calcium Channel Type L, Phenylalkylamine 73% .746uM .725uM View
calcium channel, voltage-dependent, beta 3 subunit PHENTOLAMINE Calcium Channel Type L, Phenylalkylamine 73% .746uM .725uM View
calcium channel, voltage-dependent, beta 2 subunit PHENTOLAMINE Calcium Channel Type L, Phenylalkylamine 73% .746uM .725uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit PHENTOLAMINE Calcium Channel Type L, Phenylalkylamine 73% .746uM .725uM View
calcium channel, voltage-dependent, alpha 1F subunit PHENTOLAMINE Calcium Channel Type L, Phenylalkylamine 73% .746uM .725uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit PHENTOLAMINE Calcium Channel Type L, Phenylalkylamine 73% .746uM .725uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit PHENTOLAMINE Calcium Channel Type L, Phenylalkylamine 73% .746uM .725uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit PHENTOLAMINE Calcium Channel Type L, Phenylalkylamine 73% .746uM .725uM View
calcium channel, voltage-dependent, beta 1 subunit PHENTOLAMINE Calcium Channel Type L, Phenylalkylamine 73% .746uM .725uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit PHENTOLAMINE Calcium Channel Type L, Phenylalkylamine 73% .746uM .725uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit PHENTOLAMINE Calcium Channel Type L, Phenylalkylamine 73% .746uM .725uM View